| Dr Robert K Wolter, MD | |
|
20 N Church St, Elkhorn, WI 53121-0227 | |
| (262) 723-6811 | |
| (262) 723-2321 |
| Full Name | Dr Robert K Wolter |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Location | 20 N Church St, Elkhorn, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275640153 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 23309 (Wisconsin) | Primary |
| 207Y00000X | Otolaryngology | 36072035 (Illinois) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert K Wolter, MD 3301 W Forest Home Ave, Milwaukee, WI 53215-2843 Ph: (414) 647-6326 | Dr Robert K Wolter, MD 20 N Church St, Elkhorn, WI 53121-0227 Ph: (262) 723-6811 |
News Archive
A woman's mental health during pregnancy has a direct influence on the development of her child's immune system, according to a new study from pediatric researchers at the University of Alberta.
People suffering from diabetes-related foot ulcers show different rates of healing according to the way they cope and their psychological state of mind, according to new research by a health psychologist at The University of Nottingham.
Long the stuff of science fiction, the disembodied "brain in a jar" is providing science fact for UC Irvine researchers, who by studying the whole brains of fruit flies are discovering the inner mechanisms of jet lag.
Boehringer Ingelheim today announced that the U.S. Food and Drug Administration accepted for review the New Drug Application (NDA) for the fixed-dose combination (FDC) of tiotropium and olodaterol delivered via the Respimat inhaler for the proposed indication of long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
MAQUET Cardiovascular LLC today announced enrollment of the first patient in FINEST (FUSION Vascular Graft, FUSION Vascular Graft with BIOLINE and EXXCEL SOFT ePTFE). This prospective, randomized, single-blind, three-arm, parallel group, multi-center study is evaluating the safety and efficacy of MAQUET's investigational FUSION Vascular Graft and FUSION BIOLINE Vascular Graft, compared with its commercially available EXXCEL Soft ePTFE Vascular Graft in peripheral artery bypass surgery.
› Verified 4 days ago
Dr. Marissa Le, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 201 E Morrissy Dr, Elkhorn, WI 53121 Phone: 262-723-3100 |